Will I Go to Jail If the DEA Investigates My Practice.

An investigation is not a conviction, and a conviction is not inevitable from an investigation. The answer to the question is that many practitioners who are investigated by the DEA do not go to jail, and the outcome depends significantly on the evidence, the conduct, and the quality and timing of the legal response.

This is the same answer provided in the general federal criminal defense context: the investigation does not determine the outcome, and the practitioner who retains experienced counsel early, engages the investigation strategically, and presents a credible clinical defense is in a fundamentally different position than the practitioner who waits for an indictment before addressing the situation. The DEA opioid investigation context has specific features that make this general truth more specific.

The Range of Outcomes

DEA opioid investigations of healthcare practitioners produce a range of outcomes. At the most favorable end, the investigation produces no formal action: the government declines to pursue criminal charges, the DEA declines to initiate administrative proceedings, and the state board takes no action. Declinations occur when the evidence the investigation developed does not meet the charging standard, when the practitioner's clinical documentation successfully contextualizes the prescribing data, or when the government determines that prosecution is not warranted by the specific facts.

Below declination on the outcome spectrum are administrative resolutions that may include DEA registration conditions, state board consent orders, and OIG compliance agreements, without criminal prosecution. These outcomes preserve the practitioner's ability to practice, subject to conditions, and avoid the criminal record and incarceration that the worst case involves. They are real outcomes that experienced pre-indictment intervention has produced in cases where the underlying clinical conduct was defensible.

Below administrative resolution are criminal prosecutions that resolve through plea agreements with cooperation, through plea agreements without cooperation, and through contested trials. The sentence in a cooperated case may include probation, minimal incarceration, or a substantial sentence below the guidelines range. The sentence in a contested case depends on the jury's verdict and the court's sentencing determination.

The Factors That Affect the Outcome

The outcomes most likely to avoid incarceration share identifiable features. They involve practitioners whose medical records are adequate to support a legitimate medical purpose defense. They involve practitioners who retained experienced counsel before making statements to investigators, before producing records without legal guidance, and before making decisions that narrowed the available options. They involve practitioners who, if they cooperated, did so early enough and with information valuable enough to produce a government motion for a below-guidelines sentence. And they involve practitioners whose personal histories and characters presented a compelling mitigation narrative to the sentencing court.

The outcomes most likely to produce significant incarceration share the opposite features: sparse or fabricated medical records that cannot support a legitimate prescribing defense; voluntary statements made to investigators before counsel was retained that are inconsistent with the clinical narrative; obstructive conduct that added charges to the original investigation; and prescribing volumes so anomalous that no clinical expert could credibly defend them.

The investigation does not determine the outcome. The conduct that generated the investigation and the response to the investigation together determine it. The conduct cannot be changed. The response can be optimized, and the optimization of the response is what experienced counsel at the earliest possible stage provides.

The Statistical Picture

Federal healthcare fraud prosecutions produce convictions in the substantial majority of contested cases, for the same reasons that federal criminal prosecutions generally do: the cases that proceed to trial are cases where the government's evidence is strong enough to have sustained the decision to indict, and federal juries convict at rates that reflect that evidentiary quality. The practitioner who goes to trial in a DEA opioid fraud case should do so with a realistic assessment of the odds, an understanding of the specific legal and factual arguments available, and counsel who has tried comparable cases and who knows which defense approaches succeed in this specific context.